Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical CancerKosei Hasegawa, Keiichi Fujiwara, Yuko Kunugi et al.|Journal of Immunotherapy|2018Cited by 30